Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia ; volume:23 ; number:1 ; day:31 ; month:5 ; year:2023 ; pages:1-15 ; date:12.2023
BMC cancer ; 23, Heft 1 (31.5.2023), 1-15, 12.2023
- Creator
-
Shin, Jiwon
Kim, Min-Jung
Quan, Xingguo
Kim, Ji Woong
Lee, Sukmook
Park, SaeGwang
Jeong, Jee-Yeong
Yea, Kyungmoo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10975-3
- URN
-
urn:nbn:de:101:1-2023091208470312037054
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shin, Jiwon
- Kim, Min-Jung
- Quan, Xingguo
- Kim, Ji Woong
- Lee, Sukmook
- Park, SaeGwang
- Jeong, Jee-Yeong
- Yea, Kyungmoo
- SpringerLink (Online service)
Other Objects (12)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia
Immune thrombocytopenia (ITP)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia
Immune thrombocytopenia (ITP)
Chemotherapy-induced thrombocytopenia: literature review
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
The three pillars in treating antibody-mediated encephalitis
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort
The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia